Material Agreements

MEDICAL PROPERTIES TRUST INC entered into a asset purchase with a newly formed joint venture valued at approximately $1.1 billion (effective 2024-04-12).

“Also on April 12, 2024, the Company sold its interest in five Utah hospitals to a newly formed joint venture, generating immediate cash proceeds of approximately $1.1 billion”

MEDICAL PROPERTIES TRUST INC amended Australia Facility Amendment with Evolution Trustees Limited, as trustee for MPT Australia Realty Trust, Bank of America, N.A., as administrative agent, and the lenders party thereto (effective 2024-04-12).

“and (ii) the Fifth Amendment (the “Australia Facility Amendment”) to the Syndicated Facility Agreement, dated as of May 23, 2019, by and among the Company, the Borrower, Evolution Trustees Limited, as trustee for MPT Australia Realty Trust, Bank of America, N.A. as administrative agent and the lenders party thereto (the “Australia Facility”).”

MEDICAL PROPERTIES TRUST INC amended Credit Facility Amendment with JPMorgan Chase Bank, N.A., as administrative agent, and the lenders party thereto (effective 2024-04-12).

“On April 12, 2024, Medical Properties Trust, Inc., a Maryland corporation (the “Company”), and MPT Operating Partnership, L.P., a Delaware limited partnership and the Company’s operating partnership (the “Operating Partnership” or the “Borrower”), entered into (i) Amendment No. 1 (the “Credit Facility Amendment”) to the Second Amended and Restated Revolving Credit and Term Loan Agreement, dated as of June 29, 2022, by and among the Company, the Borrower, JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto (the “Credit Facility”),”

HERBALIFE LTD. amended Amendment with Jefferies Finance LLC and Coöperatieve Rabobank U.A., New York Branch valued at $400 million Term B Facility and $400 million Revolving Credit Facility (effective 2024-04-12).

“On April 12, 2024, the Company, HLF Financing, HII, Herbalife International Luxembourg S.à R.L., HBL IHB Operations S.à r.l., certain subsidiaries of the Company party thereto as guarantors, the lenders party thereto, each issuing bank, Jefferies Finance LLC, as administrative agent for the lenders under the term loan B facility (the “Term B Facility”) and as collateral agent, and Coöperatieve Rabobank U.A., New York Branch (“Rabobank”), as administrative agent for the lenders under the revolving credit facility (the “Revolving Credit Facility”, and together with the Term B Facility, the “Credit Facilities”), entered into an eighth amendment (the “Amendment”) to the Credit Agreement dated as of August 16, 2018 (as so amended, the “Credit Agreement”).”

HERBALIFE LTD. entered into Indenture with Citibank, N.A. valued at $800 million aggregate principal amount of 12.250% Senior Secured Notes due 2029 (effective 2024-04-12).

“On April 12, 2024, HLF Financing SaRL, LLC (“HLF Financing”) and Herbalife International, Inc. (“HII” and together with HLF Financing, the “Issuers”), each a wholly owned subsidiary of Herbalife Ltd., a Cayman Islands exempted company incorporated with limited liability (the “Company”), issued $800 million aggregate principal amount of 12.250% Senior Secured Notes due 2029 (the “Notes”) to certain initial purchasers (the “Offering”).”

COMMUNITY HEALTH SYSTEMS INC entered into Asset Purchase Agreement with Hamilton Health Care System, Inc. and certain of its affiliates (collectively, the "Purchaser") valued at $160 million in cash (effective 2024-04-18).

“On April 18, 2024, certain wholly-owned subsidiaries (the "Selling CHS Entities") of Community Health Systems, Inc. (the "Company"), entered into an Asset Purchase Agreement (the "Purchase Agreement") with Hamilton Health Care System, Inc. and certain of its affiliates (collectively, the "Purchaser").”

Childrens Place, Inc. amended Seventh Amendment to the Credit Agreement with Wells Fargo, National Association, as Administrative Agent valued at Permanent waiver of change in control event of default and permission to enter into New Mithaq Term (effective 2024-04-16).

“On April 16, 2024, the Company and certain of its subsidiaries entered into a seventh amendment to the Credit Agreement (the “Seventh Amendment”) that, among other things, permitted entering into the New Mithaq Term Loan described above and provided a permanent waiver of the change in control event of default.”

Childrens Place, Inc. entered into New Mithaq Promissory Note with Mithaq Capital SPC valued at $90 million term loan (effective 2024-04-16).

“On April 16, 2024, The Children’s Place, Inc. (the “Company”) and certain of its subsidiaries entered into a Shariah compliant, unsecured and subordinated promissory note (the “New Mithaq Promissory Note”) for $90 million in term loans with Mithaq Capital SPC (“Mithaq”), to be funded no later than April 19, 2024 (the “New Mithaq Term Loan”).”

URBAN ONE, INC. amended Sixth Waiver and Amendment with Bank of America, N.A., as administrative agent (effective 2024-04-12).

“On April 12, 2024, Urban One, Inc. (the “Company”) entered into a sixth waiver and amendment (the “Sixth Waiver and Amendment”) to the Current ABL Facility, dated as of February 19, 2021 (as amended by the Waiver and Amendment, the “Amended Current ABL Facility”), with the Company, the Company’s subsidiaries guarantors, Bank of America, N.A., as administrative agent (the “Administrative Agent”) and the lenders party thereto.”

INSEEGO CORP. terminated Loan and Security Agreement with Siena Lending Group LLC (effective 2024-04-18).

“Effective April 18, 2024, Inseego Corp. (the “Company”), exercised its right to voluntarily terminate the Loan and Security Agreement, dated as of August 5, 2022, by and among Siena Lending Group LLC, as lender (the “Lender”), Inseego Wireless, Inc. and Inseego North America LLC, as borrowers, and the Company, as guarantor (as amended, the “Loan and Security Agreement”).”

ACACIA RESEARCH CORP entered into Loan Agreement with Frost Bank, as Administrative Agent and LC Issuer, and the lenders from time to time party thereto valued at $150 million.

“BE Anadarko II, LLC (“BE Anadarko”), a subsidiary of Benchmark Energy II, LLC (together with its subsidiaries, “Benchmark”), a majority-owned subsidiary of Acacia Research Corporation (the “Company”), entered into a Loan Agreement (the “Loan Agreement”), by and among BE Anadarko, as Borrower, Frost Bank, as Administrative Agent and LC Issuer (“Frost Bank”), and the lenders from time to time party thereto (the “Lenders”), governing a new revolving credit facility (the “Revolving Credit Facility”), with a maximum aggregate credit amount of $150 million”

Vitro Biopharma, Inc. entered into securities purchase agreement with an accredited investor (effective 2023-11-16).

“(the “Company”) issued and sold to an accredited investor, in a private placement, (i) a senior secured convertible note (the “Note”) in the principal amount of $218,750, for a purchase price of $175,000”

NNN REIT, INC. amended Third Amended and Restated Credit Agreement with Wells Fargo Bank, National Association, as Joint Lead Arranger, Joint Bookrunner and Administrative Agent, Bank of America, N.A., as Joint Lead Arranger, Joint Bookrunner and Syndication Agent, and a syndicate of lenders named therein valued at $1.2 billion (effective 2024-04-16).

“NNN REIT, Inc. (the “Company”) entered into that certain Third Amended and Restated Credit Agreement, dated as of April 16, 2024 (the “Credit Agreement”), with Wells Fargo Bank, National Association, as Joint Lead Arranger, Joint Bookrunner and Administrative Agent, Bank of America, N.A., as Joint Lead Arranger, Joint Bookrunner and Syndication Agent, and a syndicate of lenders named therein.”

Daimler Trucks Retail Trust 2024-1 entered into Underwriting Agreement with J.P. Morgan Securities LLC, Scotia Capital (USA) Inc. and Deutsche Bank Securities Inc., as representatives of the several underwriters valued at $636,950,000 principal amount of Notes.

“In connection with the Asset Backed Notes (the “Notes”) to be issued by Daimler Trucks Retail Trust 2024-1 (the “Issuer”) and the $636,950,000 principal amount of Notes offered pursuant to the Prospectus dated April 15, 2024, Daimler Trucks Retail Receivables LLC (“Daimler Trucks Retail Receivables”) and Daimler Truck Financial Services USA LLC (“DTFS USA”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC, Scotia Capital (USA) Inc. and Deutsche Bank Securities Inc., as representatives of the several underwriters.”

ALLURION TECHNOLOGIES, INC. terminated Fortress Credit Agreement.

“The Company has terminated and repaid in full the outstanding borrowings and other obligations under the Fortress Credit Agreement.”

ALLURION TECHNOLOGIES, INC. amended First Amendment to the Original Note Purchase Agreement with RTW Investments, LP, as agent for the purchasers, and Acquiom Agency Services LLC (effective 2024-04-16).

“Subsequently, on April 16, 2024, the Company, the Principal Purchaser, the Purchasers and Acquiom entered into the First Amendment to the Original Note Purchase Agreement (the “Amendment”; the Original Note Purchase Agreement, as amended by the Amendment, the “Amended Note Purchase Agreement”).”

ALLURION TECHNOLOGIES, INC. entered into Original Note Purchase Agreement with RTW Investments, LP, as agent for the purchasers, and Acquiom Agency Services LLC valued at $48 million (effective 2024-04-14).

“On April 14, 2024, Allurion Technologies, Inc., a Delaware corporation (the “Company”), RTW Investments, LP (“RTW”), as agent for the purchasers (the “Purchasers”) party thereto from time to time (RTW in such capacity, the “Principal Purchaser”), and Acquiom Agency Services LLC (“Acquiom”), as collateral agent for the Purchasers and the Principal Purchaser, entered into a Note Purchase Agreement (the “Original Note Purchase Agreement”).”

Fortress Net Lease REIT entered into Purchase Agreement with certain subsidiaries of RelaDyne, Inc. (the " Seller ") valued at aggregate purchase price of $132,520,000 (effective 2024-04-11).

“a subsidiary of Fortress Net Lease REIT (the “ Company ”) entered into a purchase and sale agreement (the “ Purchase Agreement ”) with certain subsidiaries of RelaDyne, Inc. (the “ Seller ”), pursuant to which a subsidiary of the Company acquired a portfolio of 27 industrial properties from the Seller for an aggregate purchase price of $132,520,000”

Trio Petroleum Corp entered into Security Agreement with an institutional investor (effective 2024-04-16).

“To secure the obligations of the Company to repay the Investor Note, the Company has granted to the Investor a senior security interest in and to all of the Company’s assets and properties, subject to certain exceptions, as set forth in that certain Security Agreement, dated April 16, 2024, between the Company and the Investor (the “Security Agreement”).”

Trio Petroleum Corp entered into Investor Note with an institutional investor valued at $400,000 (effective 2024-04-16).

“In connection with the Financing, the Company issued a Senior Secured Convertible Promissory Note to the Investor in the principal amount of $400,000, having an original issue discount of $40,000, or 10% (the “Investor Note”).”

Trio Petroleum Corp entered into SPA with an institutional investor valued at $360,000 (effective 2024-04-16).

“On April 16, 2024, Trio Petroleum Corp., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “SPA”) with an institutional investor (the “Investor”).”

Signing Day Sports, Inc. amended Amendment No. 1 to Settlement Agreement and Release with Midwestern Interactive, LLC valued at Second Tranche of $300,000 to be paid with interest at 6% per annum: $200,000 by April 12, 2024; $25 (effective 2024-04-11).

“On April 11, 2024, under an Amendment No. 1 to Settlement Agreement and Release (the “Amendment to Midwestern Release Agreement”), dated as of April 11, 2024, between Signing Day Sports, Inc., a Delaware corporation (the “Company”), and Midwestern Interactive, LLC, a Missouri limited liability company (“Midwestern”), the Company and Midwestern agreed to amend the Settlement Agreement and Release, dated as of December 12, 2023, between the Company and Midwestern (the “Midwestern Release Agreement”).”

MultiSensor AI Holdings, Inc. entered into Common Stock Purchase Agreement with B. Riley Principal Capital II, LLC valued at up to $25,000,000 (effective 2024-04-16).

“On April 16, 2024, MultiSensor AI Holdings, Inc. (the “ Company ”) entered into a Common Stock Purchase Agreement (the “ Purchase Agreement ”) and a related Registration Rights Agreement (the “ Registration Rights Agreement ”), each dated as of April 16, 2024, with B. Riley Principal Capital II, LLC (“ B. Riley Principal Capital II ”).”

TortoiseEcofin Acquisition Corp. III entered into Loan and Transfer Agreements with TortoiseEcofin Sponsor III LLC, One Energy Enterprises Inc., and other parties (the Lenders) valued at $350,000 (effective 2024-04-11).

“On April 11, 2024, TortoiseEcofin Acquisition Corp. III (the “ Company ”) entered into Loan and Transfer Agreements with TortoiseEcofin Sponsor III LLC, the Company’s sponsor (the “ Sponsor ”), One Energy Enterprises Inc. (“ One Energy ”) and other parties (the “ Lenders ”), pursuant to which the Lenders agreed to loan an aggregate of $350,000 to the Sponsor (the “ Loan ”) and the Sponsor intends to loan such amount to the Company (the “ SPAC Loan ”).”

Marpai, Inc. entered into Securities Purchase Agreement with the Purchasers valued at $11,830,000 (effective 2024-04-15).

“On April 15, 2024, Marpai, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with each of the purchasers that are parties thereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”) and JGB Collateral LLC, a Delaware limited liability company, as collateral agent for the Purchasers (the “Agent”).”

AEON Biopharma, Inc. entered into Convertible Note with Daewoong Pharmaceutical Co., LTD. valued at $10.0 million (effective 2024-04-12).

“on April 12, 2024, AEON issued and sold to Daewoong one senior secured convertible note (the “Convertible Note”) in the principal amount of $10.0 million.”

Clever Leaves Holdings Inc. terminated Equity Distribution Agreement with Canaccord Genuity LLC valued at $50,000,000 (effective 2024-04-26).

“On April 16, 2024, Clever Leaves Holdings Inc. (the “Company”) provided a notice to Canaccord Genuity LLC (“Canaccord”) to terminate that certain Equity Distribution Agreement, dated January 14, 2022, between the Company and Canaccord (the “Equity Distribution Agreement”).”

TScan Therapeutics, Inc. entered into Underwriting Agreement with Morgan Stanley & Co. LLC and TD Securities (USA) LLC valued at $144.7 million (effective 2024-04-16).

“On April 16, 2024, TScan Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC and TD Securities (USA) LLC, as representatives (the “Representatives”) of the underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to issue and sell an aggregate of (a) 2,472,581 shares (the “Firm Shares”) of its voting common stock, par value $0.0001 per share (the “Voting Common Stock”), at a price to the public of $7.1300 per share, and (b) pre-funded warrants to purchase up to 18,577,419 shares of the Company’s Voting Common Stock (the “Pre-Funded Warrants”), at a price to the public of $7.1299 per warrant with an exercise price of $0.0001 per share (the “Offering”).”

Amerant Bancorp Inc. entered into Purchase and Assumption Agreement with MidFirst Bank valued at approximately $576.0 million and $529.0 million, respectively (effective 2024-04-16).

“On April 16, 2024, Amerant Bank, N.A. (the “Bank”), a wholly-owned subsidiary of Amerant Bancorp Inc. (the “Company”), entered into a Purchase and Assumption Agreement (the “Purchase Agreement”) with MidFirst Bank (“MidFirst”) pursuant to which MidFirst will purchase certain assets and assume certain liabilities (the “Transaction”) of the banking operations and six branches in the Houston, Texas metropolitan statistical area (collectively, the “Branches”).”

Sadot Group Inc. amended Standby Equity Purchase Agreement with YA II PN, Ltd. valued at Amended terms of remaining outstanding Note: payments of $350,000 plus 8% premium and accrued intere (effective 2024-04-10).

“On April 10, 2024, the Company and the Investor entered into a letter agreement (the “ Letter Agreement ”) to amend the terms of the remaining outstanding Note providing that the Company will make payments on May 1, 2024, June 1, 2024 and July 1, 2024 each in the principal amount of $350,000 plus an 8% payment premium and accrued interest. During the period through August 1, 2024, the Investor agreed that the application of any monthly payments that may become due and payable pursuant to Section 1(c) of the Notes (i.e., as a result of a Floor Price Trigger, or Exchange Cap Trigger) shall be suspended and the Investor shall not effect any Investor Notices of Conversions Notices, unless the Conversion Price is equal to the Fixed Price as such terms are defined in the SEPA, or with the consent of the Company.”

Southwest Gas Holdings, Inc. entered into Separation Agreement with Centuri Holdings, Inc. valued at Separation of Centuri Group, Inc. business (effective 2024-04-11).

“On April 11, 2024, Southwest Gas Holdings, Inc. (the "Company") entered into several agreements with Centuri Holdings, Inc. ("Centuri"), a wholly-owned subsidiary of the Company, in connection with the separation of the business, assets and liabilities comprising Centuri Group, Inc., the Company's strategic utility infrastructure services business ("Centuri Group"), from the Company and the transfer of Centuri Group to Centuri (the "Separation").”

Great Elm Capital Corp. entered into Sixth Supplemental Indenture with Equiniti Trust Company, LLC valued at $30,000,000 (effective 2024-04-17).

“On April 17, 2024, Great Elm Capital Corp. (the “Company”) and Equiniti Trust Company, LLC (f/k/a American Stock Transfer & Trust Company, LLC), as trustee (the “Trustee”), entered into a sixth supplemental indenture (the “Sixth Supplemental Indenture”) to the indenture, dated September 18, 2017, between the Company and the Trustee (as supplemented by the Sixth Supplemental Indenture, the “Indenture”).”

Skyline Bankshares, Inc. entered into Agreement and Plan of Merger with Johnson County Bank valued at $25.0 million (effective 2024-04-16).

“On April 16, 2024, Skyline Bankshares, Inc. (the “Company”), Skyline National Bank, a wholly-owned bank subsidiary of the Company (the “Bank”), Skyline Merger Sub, Inc., also a wholly-owned subsidiary of the Company (the “Merger Sub”) and Johnson County Bank (“JCB”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which the Company will acquire JCB.”

Tri-State Generation & Transmission Association, Inc. entered into Membership Withdrawal Agreement with United Power, Inc. (effective 2024-04-11).

“On April 11, 2024, Tri-State and United Power executed an updated Membership Withdrawal Agreement ("UP Withdrawal Agreement") that was filed with FERC on April 12, 2024 in FERC Docket No. ER24-1145-000.”

SKYX Platforms Corp. amended Amendment to Letter Agreement with GE Trademark Licensing, Inc. valued at amendment extending deadline for issuing convertible note to May 1, 2024 (effective 2024-04-11).

“On April 11, 2024, the Company entered into an amendment to the Letter Agreement, which extended the deadline for the Company to issue the convertible note to GE-TL to May 1, 2024, and issued the Note, reflecting a reduction in payments due.”

Harvard Apparatus Regenerative Technology, Inc. entered into Securities Purchase Agreements with certain investors valued at $1.5 million (effective 2024-04-15).

“On April 15, 2024, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into Securities Purchase Agreements (each a “Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the Investors agreed to purchase in a private placement an aggregate of 367,767 shares of common stock for the aggregate purchase price of $1.5 million and a purchase price per unit of $4.03 (the “Private Placement”).”

Delek Logistics Partners, LP entered into First Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $200,000,000 8.625% senior notes due 2029 (effective 2024-04-17).

“On April 17, 2024, Delek Logistics Partners, LP, a Delaware limited partnership (the “ Partnership ”), and Delek Logistics Finance Corp., a Delaware corporation and a wholly owned subsidiary of the Partnership (“ Finance Corp. ” and together with the Partnership, the “ Issuers ”), issued an additional $200,000,000 in aggregate principal amount of their 8.625% senior notes due 2029 (the “ Additional Notes ”).”

HA Sustainable Infrastructure Capital, Inc. entered into Credit Agreement with JPMorgan Chase Bank, N.A. valued at $1.250 billion (effective 2024-04-12).

“On April 12, 2024, Hannon Armstrong Sustainable Infrastructure Capital, Inc. (the “Company”) through its indirect subsidiaries as borrowers entered into a new $1.250 billion, 4-year unsecured revolving credit facility pursuant to a CarbonCount ® -based revolving credit agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A. (“JPMorgan”) as administrative agent, sole bookrunner and sustainability structuring agent”

INVO Fertility, Inc. amended Amendment to the Warrant Agent Agreement with Transfer Online, Inc. (effective 2024-04-17).

“On April 17, 2024, the Company and the Warrant Agent entered into an Amendment to the Warrant Agent Agreement (the “Amendment”) to confirm that the Company may adjust the exercise price of the of the Warrants to provide an exercise price per share that is lower than the then-current exercise price of the Warrants.”

Progressive Care Inc. entered into Merger Agreement and Plan of Reorganization with NextPlat Corp (effective 2024-04-12).

“On April 12, 2024, Progressive Care Inc., a Delaware corporation (the “ Company ”) entered into a Merger Agreement and Plan of Reorganization (the “ Merger Agreement ”) with NextPlat Corp”

Research Solutions, Inc. entered into PNC Loan Agreement with PNC Bank, National Association valued at secured revolving line of credit of $500,000 (effective 2024-04-15).

“On April 15, 2024, Research Solutions, Inc. (the “ Company ”) and Reprints Desk, Inc., a wholly owned subsidiary of the Company (collectively and individually, the “ Borrower ”) entered into a Loan Agreement (the “ PNC Loan Agreement ”) with PNC Bank, National Association (“ PNC ”), as lender.”

TransMontaigne Partners LLC amended Amendment No. 2 with Barclays Bank PLC, as administrative agent and collateral agent, and the lenders party thereto valued at $150 million (effective 2024-04-15).

“TransMontaigne Partners LLC (the “Company”), as parent guarantor, and TransMontaigne Operating Company L.P., a Delaware limited partnership and wholly owned subsidiary of the Company (“OpCo”), entered into an Amendment No. 2 (the “Amendment”) to its existing Credit Agreement dated as of November 17, 2021 among the Company, OpCo, Barclays Bank PLC, as administrative agent and collateral agent, and the lenders party thereto, which provides for, among other things, the incurrence of a new tranche of term loans under the credit facility in an aggregate principal amount of $150 million (the “Incremental Term Loan Facility”).”

Vanda Pharmaceuticals Inc. entered into Rights Agreement with Equiniti Trust Company, LLC (effective 2024-04-17).

“The complete terms of the Rights are set forth in a Rights Agreement (the “Rights Agreement”), dated as of April 17, 2024, between the Company and Equiniti Trust Company, LLC, a limited trust company organized under the laws of the State of New York, as rights agent.”

ARES CAPITAL CORP amended BNP Funding Facility with BNP valued at Seventh Amendment to the Revolving Credit and Security Agreement; adjusted interest rate margin from (effective 2024-04-12).

“On April 12, 2024, the Company and ARCC FB Funding LLC, a wholly owned subsidiary of the Company (“AFB LLC”), amended the document governing AFB LLC’s revolving funding facility (the “BNP Funding Facility”) by entering into a Seventh Amendment to the Revolving Credit and Security Agreement (the “BNP Amendment”).”

ARES CAPITAL CORP amended A&R Credit Facility with JPMorgan Chase Bank, N.A. valued at Amended and restated senior secured credit facility; total commitment reduced from approximately $4. (effective 2024-04-12).

“On April 12, 2024, Ares Capital Corporation (the “Company”) amended and restated its senior secured credit facility, among the Company, the lenders party thereto, and JPMorgan Chase Bank, N.A., as the administrative agent (as amended and restated, the “A&R Credit Facility”).”

BATTALION OIL CORP amended Fourth Amendment with Fury Resources, Inc. and San Jacinto Merger Sub, Inc. (effective 2024-04-16).

“On April 16, 2024, Battalion Oil Corporation, a Delaware corporation (the " Company " or " we "), Fury Resources, Inc., a Delaware corporation (" Parent "), and San Jacinto Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (" Merger Sub "), entered into a Fourth Amendment (the " Fourth Amendment ") to the Agreement and Plan of Merger, dated as of December 14, 2023 (the " Merger Agreement "), by and among the Company, Parent and Merger Sub”

NETLIST INC amended Fourth Amendment with Equiniti Trust Company, LLC (effective 2024-04-17).

“fourth amendment (the “Fourth Amendment”) to the Rights Agreement. The Fourth Amendment appoints Equiniti Trust Company,”

ABVC BIOPHARMA, INC. entered into Oncox Agreement with OncoX BioPharma, Inc. valued at $6,250,000 (or 1,250,000 Oncox shares valued at $5 per share) (effective 2024-04-16).

“On April 16, 2024, the Company entered into a definitive agreement with OncoX BioPharma, Inc., a private company registered in the British Virgin Islands (" Oncox "), pursuant to which the Company will grant Oncox an exclusive right to develop and commercialize ABVC's single-herb botanical drug extract from the dry fruit body of Maitake Mushroom (Grifola Frondosa) for treatment of Non-Small Cell Lung Cancer (the “ Licensed Products ”), within North America for 20 years (the “ Oncox Agreement ”).”

EXACT SCIENCES CORP entered into Fifth Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $620,709,000 aggregate principal amount of 1.75% Convertible Senior Notes due 2031 (effective 2024-04-17).

“completed the closing of the transactions contemplated by those exchange and purchase agreements dated April 10, 2024 (the “Agreements”) entered into with certain holders (the “Holders”) of the Company’s 0.375% Convertible Senior Notes due 2028 (the “2028 Notes”). Pursuant to the terms of the Agreements, the Company issued to the Holders $620,709,000 aggregate principal amount of 1.75% Convertible Senior Notes due 2031 (the “2031 Notes”) in exchange for $359,662,000 aggregate principal amount of the Holders’ 2028 Notes and $266,750,000 in cash. The 2031 Notes were issued pursuant to an indenture dated as of January 17, 2018 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), as supplemented by the fifth supplemental indenture dated as of April 17, 2024 (the “Supplemental Indenture” and together with the Base Indenture, the “Indenture”).”

CORCEPT THERAPEUTICS INC entered into Sublease with Zuora, Inc. valued at base rent of an average of $1.4 million annually and Shared Amenities Space base rent of an average (effective 2024-04-12).

“On April 12, 2024, Corcept Therapeutics Incorporated (“Corcept”) entered into a sublease (the “Sublease”) with Zuora, Inc. for a portion of the premises located at 101 Redwood Shores Parkway, Redwood City, California 94065 (the “Building”).”